KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:CERC
Delisted

Cerecor Inc. Stock Price (Quote)

$0.319
+0.0060 (+1.92%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.202 $0.502 Friday, 27th May 2022 CERC stock ended at $0.319. This is 1.92% more than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 9.33% from a day low at $0.300 to a day high of $0.328.
90 days $0.202 $0.94
52 weeks $0.202 $3.70

Historical Cerecor Inc. prices

Date Open High Low Close Volume
Jan 10, 2020 $4.98 $5.18 $4.81 $4.93 164 863
Jan 09, 2020 $4.56 $4.83 $4.56 $4.68 72 539
Jan 08, 2020 $4.44 $4.73 $4.44 $4.67 68 907
Jan 07, 2020 $4.42 $4.60 $4.28 $4.48 45 806
Jan 06, 2020 $4.53 $4.88 $4.26 $4.51 213 807
Jan 03, 2020 $4.99 $5.25 $4.51 $4.71 90 767
Jan 02, 2020 $5.37 $5.37 $4.95 $5.03 77 603
Dec 31, 2019 $5.14 $5.41 $5.00 $5.39 62 028
Dec 30, 2019 $5.13 $5.33 $4.23 $5.20 219 672
Dec 27, 2019 $5.49 $5.60 $5.10 $5.13 75 122
Dec 26, 2019 $5.76 $5.88 $5.43 $5.50 66 901
Dec 24, 2019 $5.25 $6.19 $5.25 $5.71 693 340
Dec 23, 2019 $4.34 $5.31 $4.29 $5.28 528 653
Dec 20, 2019 $4.31 $4.47 $4.20 $4.28 116 794
Dec 19, 2019 $4.02 $4.59 $4.02 $4.28 117 097
Dec 18, 2019 $4.46 $4.46 $3.98 $4.34 99 103
Dec 17, 2019 $4.47 $4.47 $4.30 $4.39 38 060
Dec 16, 2019 $4.45 $4.52 $4.07 $4.47 89 667
Dec 13, 2019 $4.74 $4.79 $4.26 $4.41 130 819
Dec 12, 2019 $4.16 $4.67 $4.04 $4.40 141 072
Dec 11, 2019 $3.92 $4.58 $3.90 $4.18 201 774
Dec 10, 2019 $3.75 $4.01 $3.68 $3.84 101 644
Dec 09, 2019 $4.00 $4.00 $3.67 $3.72 68 997
Dec 06, 2019 $3.44 $4.06 $3.44 $4.00 114 859
Dec 05, 2019 $3.71 $3.77 $3.35 $3.37 38 177
Click to get the best stock tips daily for free!

About Cerecor Inc.

Cerecor. Cerecor Inc., a clinical-stage biopharmaceutical company, develops drugs to treat patients with neurological and psychiatric disorders. It develops CERC-301 that is in Phase II development stage for the adjunctive treatment of patients with major depressive disorder (MDD); CERC-501, which is in Phase II development stage for the adjunctive treatment of MDD, as well as to treat substance use disorders; and CERC-406 that is in preclinical stage to ... CERC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT